Top 8 Precision Oncology Medicines: How Targeted Therapies Are Changing Cancer Treatment
Cancer treatment has undergone a significant transformation over the past decade. Traditional chemotherapy, though effective, affects both healthy and malignant cells, often resulting in severe side effects and a challenging recovery for patients. Today, the emergence of targeted therapies has marked a new era in oncology — one where treatments are tailored to the genetic and molecular makeup of individual tumors. These therapies aim not only to improve survival but also to enhance quality of life by minimizing unnecessary harm. Among the innovative therapies shaping modern oncology are Asparaginase Erwinia chrysanthemi, Avapritinib, Belzutifan, Binimetinib, Blinatumomab, and Brigatinib . Each offers a unique mechanism of action and addresses specific cancer types, showcasing the promise of precision medicine. Asparaginase Erwinia chrysanthemi: A Lifeline in Leukemia Care Acute lymphoblastic leukemia (ALL) is one of the most common childhood cancers, but it can also affect adults. The...